Cat. No. | Product name | CAS No. |
DC22742 |
KAB-18
A potent, selective, noncompetitive human α4β2 nAChRs negative allosteric modulator with IC50 of 13.5 uM, displays no inhibitory activity on Hα3β4 nAChRs at 100 uM.. |
741678-60-4 |
DC23195 |
CBR-5884
Featured
A potent, selective, noncompetitive inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH) with IC50 of 7 uM. |
681159-27-3 |
DC22449 |
PD-146176
A potent, selective, non-competitve inhibitor of 15-lipoxygenase (15-LOX) with Ki of 197 nM. |
4079-26-9 |
DC22447 |
FAAH-IN-2
A potent, selective, noncovalent FAAH inhibitor with IC50 of 28 nM toward human FAAH and 100 nM toward rat FAAH. |
1361993-03-4 |
DC22680 |
Conivaptan
A potent, selective, nonpeptide vasopressin V1A and V2 receptor antagonist with Ki of 0.48 nM and 3.04 nM respectively. |
210101-16-9 |
DC21738 |
TBC3486
A potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM, displays 200-fold selectivity over α4β7 (IC50=2.1 uM). |
247044-77-5 |
DC20617 |
AA-CW236
Featured
A potent, selective, non-pseudosubstrate inhibitor of O(6) -alkylguanine DNA methyltransferase (MGMT) with low-nanomolar potency. |
1869921-96-9 |
DC21593 |
RUC-4
Featured
A potent, selective, non-RGD-mimetic αIIbβ3 integrin receptor antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors. . |
1448313-27-6 |
DC23596 |
Luseogliflozin
A potent, selective, orally acitve SGLT2 inhibitor with IC50 of 2.26 nM, 1650-fold selectivity over SGLT1. |
898537-18-3 |
DC21307 |
MKC-733
A potent, selective, orally active 5-HT3 receptor agonist with high affinity for canine intestinal smooth muscle 5-HT3 receptors. |
194093-42-0 |
DC21606 |
SB-357134
A potent, selective, orally active and CNS penetrant 5-HT6 receptor antagonist with pKi of 8.5, displays 1300-fold selectivity over other 13 5-HT receptor subtypes. |
219963-52-7 |
DC20774 |
VTP 37948
A potent, selective, orally active BACE1 inhibitor for the treatment of Alzheimer's disease.. |
|
DC20665 |
AMG 8718
A potent, selective, orally active BACE1 inhibitor with IC50 of 0.7 nM, demonstrates limited selectivity for over BACE2 and high selectivity both renin and pepsin. |
1215868-94-2 |
DC20324 |
BRS-3 agonist Compound A
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 250/100 nM for human/rat BRS-3, resp+H1437+M1438. |
|
DC20325 |
BRS-3 agonist Compound A racemate
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 270/130 nM for human/rat BRS-3, respectively. |
|
DC21187 |
JTE907
Featured
A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively. |
282089-49-0 |
DC21793 |
VER-250840
A potent, selective, orally active Chk1 inhibitor with IC50 of < 1 nM, Ki=69 pM. |
|
DC22898 |
L-365260
A potent, selective, orally active cholecystokinin receptor 2 (CCK2) antagonist with IC50 of 2 nM. |
118101-09-0 |
DC22485 |
Gefitinib hydrochloride
Featured
A potent, selective, orally active EGFR inhibitor with IC50 of 23 nM. |
184475-55-6 |
DC21443 |
ONO-5334
A potent, selective, orally active inhibitor of cathepsin K with Ki of 0.1 nM, 0.049 nM and 0.85 nM for human, rabbit and rat cathepsin K, respectively. |
868273-90-9 |
DC23340 |
CCT-251455
A potent, selective, orally active monopolar spindle 1 (MPS1) inhibitor with IC50 of 3 nM, with no activity for CDK2 and Aurora A (IC50>40 uM). |
1400284-80-1 |
DC25200 |
PF-1355
Featured
PF-1355 is a potent, selective, orally active Myeloperoxidase (MPO) inhibitor with EC50 of 1.47 uM. |
1435467-38-1 |